UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Diabetes care, ISSN 0149-5992, 06/2014, Volume 37, Issue 6, pp. 1767 - 1770
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Metabolic diseases | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - therapeutic use | Tissue Distribution | Hypoglycemic Agents - pharmacokinetics | Body Weight | Humans | Diabetes Mellitus - drug therapy | Quality of Life | Insulin - analogs & derivatives | Patient Compliance | Insulin - pharmacokinetics | Insulin - therapeutic use | Patient Satisfaction | Care and treatment | Analysis | Dosage and administration | Pharmacology | Diabetes | Pharmacokinetics | Insulin | Hypoglycemia | Risk assessment | Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 12/2019, Volume 42, Issue 12, pp. 2167 - 2170
Journal Article
Diabetes care, ISSN 0149-5992, 2014, Volume 37, Issue 6, pp. 1767 - 1770
Journal Article
4.
Full Text
Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?
Current diabetes reports, ISSN 1534-4827, 4/2017, Volume 17, Issue 4, pp. 1 - 12
Drug side effects | Antidiabetic medications | Diabetes | Type 2 diabetes mellitus | Medicine & Public Health | Treatment of type 2 diabetes | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Thiazolidinediones - therapeutic use | Prospective Studies | Biguanides - therapeutic use | Humans | Sulfonylurea Compounds - therapeutic use | Biguanides - adverse effects | Sulfonylurea Compounds - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Thiazolidinediones - adverse effects | Glucagon-Like Peptide-1 Receptor - agonists | Type 2 diabetes | Complications and side effects | Hypoglycemic agents | Drug therapy, Combination | Drug approval | Diabetes therapy | Index Medicus
Journal Article
5.
Full Text
Continuous glucose monitoring: Musing on our progress in memory of Dr Andrew Jay Drexler
Journal of diabetes, ISSN 1753-0393, 10/2020, Volume 12, Issue 10, pp. 772 - 774
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 11/2014, Volume 70, Issue 11, pp. 1277 - 1289
Biomedicine | Incretin hormones | Dipeptidyl peptidase-4 inhibitors | Sitagliptin | Alogliptin | Vildagliptin | Linagliptin | Type 2 diabetes mellitus | Pharmacology/Toxicology | Glucagon-like peptide1 | Saxagliptin | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Diabetes. Impaired glucose tolerance | Pharmacology. Drug treatments | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Treatment Outcome | Diabetes Mellitus, Type 2 - drug therapy | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Type 2 diabetes | Glucose metabolism | Medical colleges | Peptides | Hemoglobin | Glucose | Dextrose | Pharmacology | Inhibitor drugs | Diabetes | Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 11/2016, Volume 39, Issue 11, pp. 2026 - 2035
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Metformin - therapeutic use | Administration, Oral | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Insulin Glargine - therapeutic use | Male | Treatment Outcome | Hypoglycemia - drug therapy | Peptides - administration & dosage | Insulin Glargine - administration & dosage | Hypoglycemic Agents - administration & dosage | Endpoint Determination | Postprandial Period | Female | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Drug Combinations | Peptides - therapeutic use | Type 2 diabetes | Care and treatment | Dosage and administration | Insulin glargine | Metformin | Drug therapy | Clinical trials | Side effects | Diabetes | Product safety | Insulin | Pharmaceuticals | Index Medicus
Journal Article
Endocrine practice, ISSN 1530-891X, 2011, Volume 17, pp. 1 - 53
Journal Article
Diabetes care, ISSN 0149-5992, 10/2014, Volume 37, Issue 10, pp. e232 - e232
Journal Article
Diabetes care, ISSN 0149-5992, 10/2014, Volume 37, Issue 10, p. e232
Journal Article
Endocrine practice, ISSN 1530-891X, 07/2015, Volume 21, pp. 1 - 87
Journal Article